Pitching Endpoints News Artificial Intelligence Reporters: Vertical Press Strategy
Endpoints News covers the business of biotech and pharma with an investor-grade lens. Its AI beat sits at the intersection of drug discovery, clinical development, and health data.
This guide is built for PR teams pitching Endpoints News Artificial Intelligence reporters who want signal over spin. Expect short paragraphs, hard data, and a newsroom that rewards domain fluency.
Editorial Scope: What Endpoints News Covers in Artificial Intelligence#
Endpoints treats AI as a biopharma business story, not a general tech story. The beat tracks AI-driven drug discovery, clinical trial tooling, diagnostics, and the capital flowing into them.
Coverage skews toward deals, funding rounds, regulatory milestones, and platform claims that can be stress-tested. Pure "AI hype" angles are largely filtered out.
💡 Vertical Pro Tip: Frame every pitch as a business or scientific consequence — a deal, a trial readout, a regulatory decision — not as an AI capability showcase.
Identifying Active Writers on the Endpoints News Artificial Intelligence Reporters List#
The AI beat is lean. Treat the Endpoints News Artificial Intelligence reporters list as a short, high-value target set rather than a broad distribution list.
Ngai Yeung is a representative writer in our directory for this vertical. Verify current bylines and beat focus before each send, since biotech newsrooms rotate coverage quickly.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Writer targeting | Pitch the named AI-beat writer directly | Blast emails to the general newsroom |
| Beat fit | Tie AI to a biopharma commercial or clinical outcome | Generic "AI is transforming healthcare" framing |
| News hook | Lead with a deal, data readout, or filing | Company background and vision statements |
| Timing | Send on breaking-news days with a fresh angle | Pitches sent after a cycle has closed |
Angles & Data Points That Resonate With Endpoints News Artificial Intelligence Journalists#
Endpoints News Artificial Intelligence journalists respond to numbers they can verify: trial endpoints, model performance against benchmarks, and deal economics.
Lead with the why now. A new partnership, an FDA interaction, or a competitive readout gives the beat a reason to publish.
High-conversion angles
- Deal mechanics: Who is paying whom, how much, and what milestones trigger payment.
- Clinical evidence: AI-derived targets or biomarkers with measurable outcomes.
- Capital and valuation: Funding rounds with named investors and defensible valuation logic.
- Regulatory friction: How AI tools clear FDA or EMA review pathways.
💡 Vertical Pro Tip: Offer an independent expert — a biostatistician, clinician, or investor — who can critique your claim. Endpoints values balanced sourcing over single-voice promotion.
Outreach Protocols & Accessing Endpoints News Artificial Intelligence Journalists Contacts#
Build Endpoints News Artificial Intelligence journalists contacts from verified bylines, the outlet's staff page, and recent article author tags. Never rely on stale lists.
Keep the first email under 120 words. Put the news in the subject line and the first sentence, then offer data and an interview.
Outreach sequence
- Day 0: Short pitch with the hook, one hard data point, and an expert offer.
- Day 3: One follow-up with a new angle or fresh data — never a "just checking in."
- Day 7: Final nudge only if the story is still live; otherwise pause.
Respect embargoes precisely and never pitch the same exclusive to a competing biotech outlet. Endpoints trades on trust with its readership.
Fast-Action Pitch Checklist for Artificial Intelligence#
Run this checklist before every send to the AI beat.
- Is the hook a business or clinical event, not an AI feature?
- Does the subject line name the company and the news in under 10 words?
- Is there at least one verifiable number (deal size, endpoint, benchmark)?
- Have I confirmed the current AI-beat writer via recent bylines?
- Is an independent expert available for balance?
- Is the pitch under 120 words with a clear ask?
💡 Vertical Pro Tip: Keep a living Endpoints News Artificial Intelligence reporters list with last-article dates. A writer who hasn't touched the beat in 60 days is a routing risk, not a target.
Pitch the AI beat as a biopharma business desk and you'll earn the read. Lead with evidence, respect the newsroom's rigor, and the Endpoints News Artificial Intelligence reporters will keep your name on file.